These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 8041965)

  • 1. High mortality and poor quality of life during predialysis period in type II diabetic patients with diabetic nephropathy.
    Biesenbach G; Zazgornik J
    Ren Fail; 1994; 16(2):263-72. PubMed ID: 8041965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Similar rate of progression in the predialysis phase in type I and type II diabetes mellitus.
    Biesenbach G; Janko O; Zazgornik J
    Nephrol Dial Transplant; 1994; 9(8):1097-102. PubMed ID: 7800207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rate of decline of GFR and progression of vascular disease in type 2 diabetic patients with diabetic or vascular nephropathy during the last three years before starting dialysis therapy.
    Biesenbach G; Schmekal B; Pieringer H; Janko O
    Kidney Blood Press Res; 2006; 29(5):267-72. PubMed ID: 17035711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients.
    Biesenbach G; Grafinger P; Janko O; Zazgornik J
    Clin Nephrol; 1997 Sep; 48(3):146-50. PubMed ID: 9342485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abysmal prognosis of patients with type 2 diabetes entering dialysis.
    Chantrel F; Enache I; Bouiller M; Kolb I; Kunz K; Petitjean P; Moulin B; Hannedouche T
    Nephrol Dial Transplant; 1999 Jan; 14(1):129-36. PubMed ID: 10052492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic.
    Al-Wakeel JS; Hammad D; Al Suwaida A; Mitwalli AH; Memon NA; Sulimani F
    Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):77-85. PubMed ID: 19112222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephrotic range proteinuria as a strong risk factor for rapid renal function decline during pre-dialysis phase in type 2 diabetic patients with severely impaired renal function.
    Kitai Y; Doi Y; Osaki K; Sugioka S; Koshikawa M; Sugawara A
    Clin Exp Nephrol; 2015 Dec; 19(6):1037-43. PubMed ID: 25680889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of overt diabetic nephropathy in patients with noninsulin-dependent diabetes mellitus.
    Norymberg C; Shenkman L
    Isr J Med Sci; 1991 Mar; 27(3):124-30. PubMed ID: 2016150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II).
    Freedman BI; Wuerth JP; Cartwright K; Bain RP; Dippe S; Hershon K; Mooradian AD; Spinowitz BS
    Control Clin Trials; 1999 Oct; 20(5):493-510. PubMed ID: 10503809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.
    Gall MA; Nielsen FS; Smidt UM; Parving HH
    Diabetologia; 1993 Oct; 36(10):1071-8. PubMed ID: 8243857
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular complications in patients with diabetic nephropathy receiving pharmacological versus renal replacement therapy.
    Głowińska I; Grochowski J; Małyszko J
    Pol Arch Med Wewn; 2008; 118(7-8):404-12. PubMed ID: 18714735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for progression of renal disease in patient with diabetic nephropathy.
    Unsal A; Koc Y; Basturk T; Akgun AO; Sakaci T; Ahbap E
    Eur Rev Med Pharmacol Sci; 2012 Jul; 16(7):878-83. PubMed ID: 22953635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uncontrolled hypertension is associated with a rapid progression of nephropathy in type 2 diabetic patients with proteinuria and preserved renal function.
    Baba T; Murabayashi S; Tomiyama T; Takebe K
    Tohoku J Exp Med; 1990 Aug; 161(4):311-8. PubMed ID: 2256104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic patients treated with dialysis: complications and quality of life.
    Sørensen VR; Mathiesen ER; Watt T; Bjorner JB; Andersen MV; Feldt-Rasmussen B
    Diabetologia; 2007 Nov; 50(11):2254-62. PubMed ID: 17876568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of diabetic nephropathy with angiotensin II receptor antagonist.
    Lewis EJ; Lewis JB
    Clin Exp Nephrol; 2003 Mar; 7(1):1-8. PubMed ID: 14586737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinuric renal disease in type 2 diabetes-is remission of proteinuria associated with improved mortality and morbidity?
    Tan J; Jaung R; Gamble G; Cundy T
    Diabetes Res Clin Pract; 2014 Jan; 103(1):63-70. PubMed ID: 24380605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemodialysis in patients older than 65 years with end-stage renal failure--comparison of outcome in patients with and without diabetes.
    Pieringer H; Biesenbach G
    Z Gerontol Geriatr; 2008 Apr; 41(2):139-45. PubMed ID: 18327697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term mortality and retinopathy in type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.